C-reactive protein (CRP) elevation in patients with abdominal aortic aneurysm is independent of the most important

Stephen A Badger1, Chee V Soong, Mark E O'Donnell

  • 1Vascular and Endovascular Surgery Department, Belfast City Hospital, Belfast, Northern Ireland, United Kingdom. StephenBadger@btinternet.com

Insights

C-reactive protein (CRP) levels are higher in patients with abdominal aortic aneurysm (AAA), particularly in larger aneurysms. The CRP gene

Area of Science:

  • Cardiovascular Disease Research
  • Biomarker Analysis
  • Genetics and Aneurysm Formation

Background:

  • C-reactive protein (CRP) is a known marker for cardiovascular disease.
  • Abdominal aortic aneurysm (AAA) is a serious vascular condition.
  • Understanding the relationship between CRP and AAA is crucial for risk assessment.

Purpose of the Study:

  • To investigate the association between C-reactive protein (CRP) serum concentration and abdominal aortic aneurysm (AAA).
  • To determine if the CRP gene is associated with the presence and size of AAA.
  • To explore the correlation between a specific CRP gene single nucleotide polymorphism (SNP) and AAA.

Main Methods:

  • Recruitment of AAA patients and healthy controls.
  • Measurement of serum CRP concentration.
  • Assessment of the CRP gene SNP rs3091244 in participants.
  • Correlation analysis of CRP levels with AAA diameter.

Main Results:

  • Significantly higher CRP concentrations were observed in AAA patients compared to controls.
  • CRP levels showed a positive correlation with AAA size, being highest in large aneurysms.
  • No significant difference in the distribution of the CRP gene SNP rs3091244 was found between cases and controls.
  • CRP serum concentration was not influenced by the assessed CRP gene SNP.

Conclusions:

  • CRP production may be linked to the presence of AAA, especially in advanced stages.
  • The studied functional SNP of the CRP gene does not appear to influence serum CRP concentration.
  • The CRP gene SNP rs3091244 is not associated with AAA formation.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...